These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17530133)

  • 21. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
    Nakagawa T; Martinez SR; Goto Y; Koyanagi K; Kitago M; Shingai T; Elashoff DA; Ye X; Singer FR; Giuliano AE; Hoon DS
    Clin Cancer Res; 2007 Jul; 13(14):4105-10. PubMed ID: 17634536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
    Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T
    Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement.
    Neven P; Brouckaert O; Van Belle V; Vanden Bempt I; Hendrickx W; Cho H; Deraedt K; Van Calster B; Van Huffel S; Moerman P; Amant F; Leunen K; Smeets A; Wildiers H; Paridaens R; Vergote I; Christiaens MR
    J Clin Oncol; 2008 Apr; 26(10):1768-9; author reply 1769-71. PubMed ID: 18519273
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlation of ER, PgR, HER-2/neu, p53, and VEGF with clinical characteristics and prognosis in Chinese women with invasive breast cancer.
    Lu X; Gu Y; Ding Y; Song W; Mao J; Tan J; Zhao H; Han X; Sun Y
    Breast J; 2008; 14(3):308-10. PubMed ID: 18476890
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving outcomes for patients with hormone receptor-positive breast cancer: back to the drawing board.
    Ellis MJ
    J Natl Cancer Inst; 2008 Feb; 100(3):159-61. PubMed ID: 18230793
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
    Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
    Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
    Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
    Richter-Ehrenstein C; Müller S; Noske A; Schneider A
    Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HER2 as marker for the detection of circulating tumor cells.
    Müller V; Pantel K
    Breast Cancer Res Treat; 2009 Oct; 117(3):535-7. PubMed ID: 19115105
    [No Abstract]   [Full Text] [Related]  

  • 33. The importance of prognostic factors in premenopausal women with breast cancer.
    Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L
    Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.
    Ivanov O; Chen F; Wiley EL; Keswani A; Diaz LK; Memmel HC; Rademaker A; Gradishar WJ; Morrow M; Khan SA; Cryns VL
    Breast Cancer Res Treat; 2008 Oct; 111(3):411-7. PubMed ID: 17968656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation does not always show a causal relationship.
    Buyukhatipoglu H; Pehlivan Y; Geyik R; Camci C; Shandiz FH
    Saudi Med J; 2007 Sep; 28(9):1462; author reply 1462. PubMed ID: 17768488
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical significance of basal-like subtype in triple-negative breast cancer.
    Yamamoto Y; Ibusuki M; Nakano M; Kawasoe T; Hiki R; Iwase H
    Breast Cancer; 2009; 16(4):260-7. PubMed ID: 19701681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lapatinib study supports cancer stem cell hypothesis, encourages industry research.
    Schmidt C
    J Natl Cancer Inst; 2008 May; 100(10):694-5. PubMed ID: 18477795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Tissue-based markers of prognosis in breast cancer].
    Kreipe H; von Wasielewski R
    Verh Dtsch Ges Pathol; 2005; 89():52-8. PubMed ID: 18035673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of breast tumors is accompanied by a decrease in expression of the Rho guanine exchange factor Tiam1.
    Stebel A; Brachetti C; Kunkel M; Schmidt M; Fritz G
    Oncol Rep; 2009 Jan; 21(1):217-22. PubMed ID: 19082465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.